<h4>Introduction</h4>Rapidly progressive interstitial lung disease (RP-ILD) from anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5) dermatomyositis (DM) is a rare condition associated with up to 63% mortality. This evidence concerns the gene IFIH1 and dermatomyositis.